Minimally Invasive Therapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Journal of Urology

Volumn 177, Issue 3, 2007, Pages 820-821

  Elhilali, Mostafa M ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; STEROID 5ALPHA REDUCTASE INHIBITOR;

COMORBIDITY; EDITORIAL; ERECTILE DYSFUNCTION; HEALTH CARE POLICY; HOSPITALIZATION; HUMAN; LOWER URINARY TRACT SYMPTOM; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REIMBURSEMENT; TRANSURETHRAL RESECTION; URINE RETENTION;

DIATHERMY; ELECTROCOAGULATION; HUMANS; LASER THERAPY, LOW-LEVEL; MALE; PROSTATIC HYPERPLASIA; SURGICAL PROCEDURES, MINIMALLY INVASIVE; URINATION DISORDERS;

EID: 33846830058     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.12.010     Document Type: Editorial

References (10)

1. Grise P., Plante M., Palmer J., Martinez-Sagarra J., Hernandez C., Schettini M., et al. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation. Eur Urol 46 (2004) 496
2. Maria G., Brisinda G., Civello I.M., Bentivoglio A.R., Sganga G., and Albanese A. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology 62 (2003) 259
3. Carter S., and Tubaro A. Relation between intraprostatic temperature and clinical outcome in microwave thermotherapy. J Endourol 14 (2000) 617
4. Ramsey E.W., and Dahlstrand C. Durability of results obtained with transurethral microwave thermotherapy in the treatment of men with symptomatic benign prostatic hyperplasia. J Endourol 14 (2000) 671
5. Tinmouth W.W., Habib E., Kim S.C., Kuo R.L., Paterson R.F., Terry C.L., et al. Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection?. J Endourol 19 (2005) 550
6. Rosario D.J., Woo H., Potts K.L., Cutinha P.E., Hastie K.J., and Chapple C.R. Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction. Br J Urol 80 (1997) 579
7. Naslund M.J., Carlson A.M., and Williams M.J. A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period. J Urol 173 (2005) 2090
8. Zlotta A.R., Giannakopoulos X., Maehlum O., Ostrem T., and Schulman C.C. Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers. Eur Urol 44 (2003) 89
9. Bachmann A., Schurch L., Ruszat R., Wyler R.F., Seifert H.H., Muller A., et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 48 (2005) 965
10. Elzayat E.A., Habib E.I., and Elhilali M.M. Holmium laser enucleation of the prostate: a size-independent new "gold standard". Urology 66 (2005) 108